TANDEM DIABETES CARE, INC. Tandem Diabetes Care, Inc. Stock
Equities
TNDM
US8753722037
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.56 USD | -2.59% |
|
+17.87% | +47.64% |
| May. 03 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
| May. 03 | Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 870M | Sales 2025 * | 959M | Capitalization | 2.89B |
|---|---|---|---|---|---|
| Net income 2024 * | -105M | Net income 2025 * | -71M | EV / Sales 2024 * | 3.15 x |
| Net cash position 2024 * | 145M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 2.9 x |
| P/E ratio 2024 * |
-27.7
x | P/E ratio 2025 * |
-41.5
x | Employees | 2,400 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.96% |
More Fundamentals
* Assessed data
More news
Latest transcript on Tandem Diabetes Care, Inc.
More recommendations
More press releases
| 1 day | +22.32% | ||
| 1 week | +26.90% | ||
| Current month | +21.89% | ||
| 1 month | +32.86% | ||
| 3 months | +95.28% | ||
| 6 months | +183.94% | ||
| Current year | +51.18% |
1 week
34.43
47.00
1 month
30.1247.00
Current year
21.8547.00
1 year
13.8247.00
3 years
13.82155.86
5 years
13.82155.86
10 years
2.14186.30
| Managers | Title | Age | Since |
|---|---|---|---|
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
Leigh Vosseller
DFI | Director of Finance/CFO | 51 | 13-08-31 |
Shannon Hansen
CMP | Compliance Officer | 58 | 21-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 63 | 19-01-02 | |
| Director/Board Member | 64 | 13-06-30 | |
Kim Blickenstaff
BRD | Director/Board Member | 71 | 07-08-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.45% | 2 M€ | +6.77% | ||
| 0.32% | 509 M€ | -.--% | ||
| 0.10% | 12 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 43.7 | -2.27% | 278 074 |
| 24-05-03 | 44.72 | +22.32% | 5,986,916 |
| 24-05-02 | 36.56 | +0.99% | 2,473,500 |
| 24-05-01 | 36.2 | -1.34% | 1,623,711 |
| 24-04-30 | 36.69 | -0.97% | 1,464,993 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotes
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Calendar
2024-05-15
- BofA Securities Health Care Conference
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
44.72
USD
Average target price
43.57
USD
Spread / Average Target
-2.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +51.18% | 2.89B | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.82B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B |
- Stock Market
- Equities
- TNDM Stock